Search Results 761-770 of 23442 for B cell lymphomas
... Cellular therapy, B-cell lymphoma, ...Lymphoma, Diffuse large b-cell lymphoma, Hairy cell leukemia, Non-Hodgkin lymphoma, T-cell lymphoma, Cutaneous t-cell ...
... B-cell lymphoma (rrDLBCL) in up to 138 participants from multiple sites. During an initial Dose Evaluation phase (first 2 cycles) to determine Dose Limiting ...
... B-cell lymphoma 2 (BCL2) inhibitor. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors. Jacksonville, Fla. This study will collect and ...
D. Radiation Oncology Medical Physicist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Breast cancer, Cutaneous t-cell lymphoma, Prostate cancer, Eye ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
... B-cell lymphoma. The study will consist of a dose-escalation stage and an ... Histologically documented B-cell lymphoma expected to express CD20 who ...
Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.